# Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis

> **NCT00663182** · PHASE4 · UNKNOWN · sponsor: **Shanghai Changzheng Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Hepatitis B Virus
- Decompensated Cirrhosis

## Interventions

- **DRUG:** Entecavir

## Key facts

- **NCT ID:** NCT00663182
- **Lead sponsor:** Shanghai Changzheng Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-01
- **Primary completion:** 2010-12
- **Final completion:** 2012-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2008-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00663182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00663182, "Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00663182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*